Esperion Therapeutics, Inc.
Market Cap
$535.31M
P/E Ratio
-5.02
EPS
$-0.54
Dividend Yield
0.00%
52-Week Range
$0.69 — $4.18
Volume
4.09M
Avg Volume
5.02M
Beta
1.11
P/E (TTM)
-5.02
Forward P/E
15.75
PEG Ratio
-0.38
P/S (TTM)
1.32
P/B (TTM)
-2.12
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.06%
ROA (TTM)
-0.05%
ROIC
—
Gross Margin
0.30%
Operating Margin
0.15%
Net Margin
—
Debt/Equity
-0.50
Current Ratio
0.56
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.67%
EPS Growth (5Y)
+0.13%
Sales Growth (3Y)
+0.79%
Sales Growth (5Y)
+0.45%
EPS Est (This Year)
$0.17
EPS Est (Next Year)
$0.22
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.71
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
197.53M
Float
234.92M
Free Float %
118.93%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NASDAQ
IPO Date
2013-06-26
Employees
304
CEO
Sheldon L. Koenig
Index Membership
—
Website
https://www.esperion.com
Esperion Therapeutics, Inc. (ESPR) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $535.31M, a P/E ratio of -5.02, ESPR is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ESPR against other stocks using dozens of fundamental and technical filters.
Esperion Therapeutics, Inc. (ESPR) has a trailing twelve-month (TTM) P/E ratio of -5.02. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Esperion Therapeutics, Inc. (ESPR) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Esperion Therapeutics, Inc. (ESPR) has a market capitalization of $535.31 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.